Understanding calcium issues in muscle function for myotonic dystrophy
Mechanism of Skeletal Muscle Calcium Dysregulation in Myotonic Dystrophy
This study is looking at how calcium problems in muscles affect people with myotonic dystrophy, and it’s testing whether certain approved medications can help improve muscle strength and breathing for those with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10849857 on NIH RePORTER |
What this research studies
This research investigates how calcium regulation in skeletal muscles is disrupted in myotonic dystrophy, a condition that affects muscle function. By using gene editing techniques in mice, researchers are recreating specific muscle defects seen in patients to study their effects on muscle strength and respiratory function. The study aims to explore whether FDA-approved calcium channel blockers can improve muscle weakness and other symptoms associated with this disease. Patients may benefit from insights gained about potential drug treatments that could alleviate their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with myotonic dystrophy, particularly those experiencing muscle weakness and respiratory issues.
Not a fit: Patients with other forms of muscular dystrophy or unrelated muscle disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that improve muscle strength and respiratory function in patients with myotonic dystrophy.
How similar studies have performed: Previous research has shown promise in using calcium channel blockers for muscle-related conditions, suggesting potential success for this approach.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Lueck, John D. — University of Rochester
- Study coordinator: Lueck, John D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.